Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
Globally, this market is expected to be worth US$40bn by 2020 and $180bn by 2030
Will receive £16m to develop new tests in a range of disease areas
To ensure proper delivery, inhalation products require APIs and carriers to be sized precisely and mixed carefully. Hosokawa Micron reviews the mixing and size reduction technologies available
Sprint will receive an upfront payment from Bayer and is eligible to receive up to €190m in milestones
Will act as a 'match-making' service between industry and academics
Patient safety demands strict quality controls for drug manufacturers, but increasing drug shortages have led to new initiatives by the regulatory authorities that aim to streamline the oversight of new drugs, production processes and facility inspections
Will boost its presence in US generics market
Non-destructive methods of product inspection can be valuable tools for investigating quality issues. Rene P Friedrichs and David M Wright, Reading Scientific Services, offer an inside view on pharmaceuticals and drug delivery devices using X-ray microtomography
Screw-Loc and 1-Clic are two leading producrts in US plastic vials market
Sharon Johnson, Senior VP, Quality, Product Development & Regulatory Affairs at Catalent, looks at how the newly created US FDA Office of Pharmaceutical Quality aims to prevent quality issues – and therefore drug shortages – arising by establishing a uniform global programme for drug quality
Four scientists win awards in Global Academic Competition for Life Science Leaders of Tomorrow
CROs and CMOs should consider different strategies when courting big biotech versus emerging or niche biopharma companies, says Nigel Walker, Managing Director, That’s Nice